Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:07:33.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T22:57:50.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial on osteosarcoma, while adding new identifiers and collaborators.
    Difference
    31%
    Check dated 2025-04-16T17:23:39.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated the trial information, indicating that the Phase 2 portion of the study will not proceed, and it has added a new revision date.
    Difference
    2%
    Check dated 2025-04-09T11:41:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-01T23:52:07.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:34:30.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.